Document Detail


Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy.
MedLine Citation:
PMID:  21352205     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Successful pregnancy relies on the adaptation of immune responses that allow the fetus to grow and develop in the uterus despite being recognized by maternal immune cells. Dendritic cells (DCs) are central to the control of immune tolerance, and their state of activation at the maternal-decidual interface is critical to the feto-maternal immunological equilibrium. So far, the involvement of circulating DCs has been investigated poorly. Therefore, in this study we investigated whether, during healthy human pregnancy, peripheral blood DCs (PBDCs) undergo changes that may be relevant to the adaptation of maternal immune responses that allow fetal tolerance. In a cross-sectional study, we analysed PBDCs by six-colour flow cytometry on whole blood samples from 47 women during healthy pregnancy progression and 24 non-pregnant controls. We demonstrated that both myeloid and plasmacytoid PBDCs undergo a state of incomplete activation, more evident in the third trimester, characterized by increased expression of co-stimulatory molecules and cytokine production but lacking human leucocyte antigen (HLA)-DR up-regulation. To investigate the contribution of soluble circulating factors to this phenomenon, we also performed culture experiments showing that sera from pregnant women added to control DCs conditioned a similar incomplete activation that was associated with reduced DC allostimulatory capacity, supporting the in vivo relevance of our findings. We also obtained evidence that the glycoprotein hormone activin-A may contribute to DC incomplete activation. We suggest that the changes of PBDCs occurring during late pregnancy may aid the comprehension of the immune mechanisms operated by the maternal immune system to maintain fetal tolerance.
Authors:
S Della Bella; S Giannelli; V Cozzi; V Signorelli; M Cappelletti; I Cetin; M L Villa
Related Documents :
23200815 - Nausea and vomiting in pregnancy: blooming or bloomin' awful? a review of the literature.
21074265 - Protein composition of microparticles shed from human placenta during placental perfusi...
21555345 - Enos activation and no function: pregnancy adaptive programming of capacitative entry r...
17885095 - Amazon forests green-up during 2005 drought.
19384115 - Associations of unscavenged anesthetic gases and long working hours with preterm delive...
9430215 - Differences in measurements of the atria of the lateral ventricle: does gender matter?
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-02-24
Journal Detail:
Title:  Clinical and experimental immunology     Volume:  164     ISSN:  1365-2249     ISO Abbreviation:  Clin. Exp. Immunol.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-11     Completed Date:  2011-06-14     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  0057202     Medline TA:  Clin Exp Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  180-92     Citation Subset:  IM    
Copyright Information:
© 2011 The Authors; Clinical and Experimental Immunology © 2011 British Society for Immunology.
Affiliation:
Department of Biomedical Sciences and Technologies, Lab of Immunology, Hospital 'L. Sacco', University of Milan, Italy. silvia.dellabella@unimi.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activins / pharmacology,  physiology
Adult
Antigen Presentation
Cells, Cultured / drug effects,  immunology
Cytokines / biosynthesis,  classification,  genetics
Dendritic Cells / immunology*,  metabolism
Female
Flow Cytometry
HLA-DR Antigens / biosynthesis,  genetics
Humans
Immune Tolerance / immunology
Inflammation
Leukocytes, Mononuclear / drug effects,  immunology
Lymphocyte Culture Test, Mixed
Maternal-Fetal Exchange
Pregnancy
Pregnancy Trimester, Third
Recombinant Proteins / pharmacology
Up-Regulation
Young Adult
Chemical
Reg. No./Substance:
0/Cytokines; 0/HLA-DR Antigens; 0/Recombinant Proteins; 0/activin A; 104625-48-1/Activins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prev...
Next Document:  The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoanti...